Phibro Animal Health enters $960M credit facility with Rabobank; delayed draw for Zoetis acquisition

PHIBRO ANIMAL HEALTH CORP

Term A-1 loans total $351M (initial $162M + delayed $189M); Term A-2 loans total $299M.
Revolving credit commitment of $310M; Term A-1 and Revolver mature July 2029, Term A-2 July 2031.
Proceeds used to refinance existing debt, pay fees, and fund Zoetis Acquisition via delayed draw facilities.
Interest rates based on Net Leverage Ratio; commitment fees 0.20%-0.35% on undrawn commitments.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.